0001209191-11-024395.txt : 20110426 0001209191-11-024395.hdr.sgml : 20110426 20110426154040 ACCESSION NUMBER: 0001209191-11-024395 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110425 FILED AS OF DATE: 20110426 DATE AS OF CHANGE: 20110426 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Lisa CENTRAL INDEX KEY: 0001349077 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 11780079 MAIL ADDRESS: STREET 1: 125 SPRING STREET CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-04-25 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001349077 Kelly Lisa C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139 0 1 0 0 SVP, Human Resources Common Stock 2011-04-25 4 M 0 953 28.84 A 43195 D Common Stock 2011-04-25 4 S 0 953 50.00 D 42242 D Common Stock 1182 I 401(k) Stock Option 28.84 2011-04-25 4 M 0 953 0.00 D 2007-10-12 2017-07-11 Common Stock 953 16204 D Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 7/12/2007. Kenneth S. Boger, Attorney-In-Fact 2011-04-26